Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 135140469
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(18)30915-X
- Title of journal
- The Lancet Oncology
- Article number
- -
- First page
- 663
- Volume
- 20
- Issue
- 5
- ISSN
- 1470-2045
- Open access status
- Exception within 3 months of publication
- Month of publication
- March
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
86
- Research group(s)
-
A - Cancer Sciences
- Citation count
- 203
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- I was involved in study concept, design organisation and conduct, data analysis and interpretation, and critiquing the intellectual content of the paper.
- Non-English
- No
- English abstract
- -
